• New Investment into Pharmaron Positions the Company for Future Growth

    11th December, 2015

    New Investment into Pharmaron Positions the Company for Future Growth Pharmaron, a fully integrated CRO, today announced that the company reached a definitive agreement with a consortium led by CITIC M&A Fund and Legend Capital for an investment of over US$280 million in the company, capitalizing Pharmaron for its future growth and allowing certain shareholders […]

    Read More
  • Pharmaron held the 5th Pharmaron Symposium in Synthetic and Medicinal Chemistry

    28th September, 2015

    BEIJING – September 12, 2015 Pharmaron held the 5th Pharmaron Symposium in Synthetic and Medicinal Chemistry in Beijing. This Symposium featured seven presentations by world sought-after leaders from both academia and biopharmaceutical industry, showcasing recent advances of innovation in synthetic and medicinal chemistry, from highly creative approaches to synthetic and medicinal chemistry challenges, to creation of […]

    Read More
  • Pharmaron Opened Ningbo Site

    27th June, 2015

    Pharmaron Opened Ningbo Site on June 26, 2015.

    Read More
  • 1st Pharmaron Symposium in DMPK and Biology Was Held on May 30, 2015

    1st June, 2015

    BEIJING – May 30, 2015. Pharmaron  held the 1st Pharmaron Symposium in DMPK & Biology. DMPK and biology are two critical components for drug discovery and development. This First International Symposium aimed to bring together highly sought–after speakers from all over the world to speak at Pharmaron Beijing. At this significant event, leaders from both academia and […]

    Read More
  • 4th Symposium – Synthetic and Medicinal Chemistry was held on September 20, 2014

    27th September, 2014

    BEIJING – September 20, 2014. As one of the major international gatherings at Pharmaron, this 4th Symposium aims to foster an exchange of knowledge and ideas among international specialists from colleges and big pharmaceutical companies. The Symposium also serves as a training platform to strengthen Pharmaron’s integrated R & D abilities, to gain additional insight about the development of the industry, and to deepen the understanding of medicinal chemistry.

    Read More